Dr. Aditya R. Sarvaria, MD

Dr. Sarvaria practices at Scripps Mercy Hospital San Diego in San Diego, California, part of Scripps Health.

Dr. Sarvaria's NPI, 1407116627, was assigned on May 22, 2012. Dr. Sarvaria graduated from New York Medical College in 2012. Dr. Sarvaria's California license number on file is A129873.

Dr. Sarvaria's primary practice is Scripps Mercy Hospital San Diego, at 4077 5th Ave, San Diego, CA 92103 in San Diego County. The practice phone is (619) 294-8111.

Dr. Sarvaria's primary practice is Scripps Mercy Hospital San Diego in San Diego, California, part of Scripps Health. Dr. Sarvaria is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Sarvaria to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarvaria practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sarvaria's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sarvaria is board certified in hematology by the American Board of Internal Medicine. Dr. Sarvaria has a license on file in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Sarvaria treats.

CMS data shows 66,116 Medicare services from Dr. Sarvaria across 50 procedure codes in 2024, for 845 Medicare patients. Medicare paid $1,333,495 for them.

CMS counts 845 Medicare patients who saw Dr. Sarvaria in 2024. The largest group is 75 to 84, with 360 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarvaria's median patient age at 66, with 55% women.

In 2024, Dr. Sarvaria wrote 1,387 Medicare Part D claims for 216 patients. 79% of them were for generic drugs. CMS names the drug for 1,058 of them, across 28 drugs with 11 or more claims each, at $2,810,904 in total drug cost. In 2023, CMS named 719 claims across 28 drugs.

Dr. Sarvaria accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarvaria as offering telehealth.

Dmand AI links 3 papers to Dr. Sarvaria, published from 2015 to 2019. The most frequent topics are Antineoplastic Agents and Leukemia, Hairy Cell. Dr. Sarvaria's most frequent co-authors are Alan Saven, MD and Zheng Zhu Topp, MD.

CMS Open Payments shows 1,054 general payments to Dr. Sarvaria from 78 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,010.

Dr. Sarvaria graduated from New York Medical College in 2012.

Dr. Sarvaria is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.